Diagnos Laboratorium Utama PT Tbk Cash Flow Reinvestment Rate
Diagnos Laboratorium Utama PT Tbk cash flow reinvestment rate. Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow Reinvestment Rate of 1.74x as of June 2025, reinvesting Rp2.64 Billion (capex Rp2.64 Billion ) from operating cash flow of Rp1.52 Billion. See Diagnos Laboratorium Utama PT Tbk (DGNS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Diagnos Laboratorium Utama PT Tbk (2018–2024)
Cash flow reinvestment rate of Diagnos Laboratorium Utama PT Tbk from 2018 to 2024. Historical reinvestment intensity for Diagnos Laboratorium Utama PT Tbk across 6 annual periods. Explore Diagnos Laboratorium Utama PT Tbk cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Diagnos Laboratorium Utama PT Tbk Cash Flow Reinvestment Rate by Year (2018–2024)
Diagnos Laboratorium Utama PT Tbk cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for Diagnos Laboratorium Utama PT Tbk. For the full cash flow conversion analysis, see Diagnos Laboratorium Utama PT Tbk (DGNS) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.59x | Rp43.39 Billion | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp38.32 Billion | Rp13.18 Billion | Rp38.32 Billion | ▲ +130.2% |
| 2021 | 1.26x | Rp74.35 Billion | Rp58.87 Billion | Rp67.84 Billion | ▲ +167.7% |
| 2020 | 0.47x | Rp12.37 Billion | Rp26.23 Billion | Rp5.86 Billion | ▼ -43.2% |
| 2019 | 0.83x | Rp9.29 Billion | Rp11.20 Billion | Rp2.78 Billion | ▼ -32.1% |
| 2018 | 1.22x | Rp10.34 Billion | Rp8.47 Billion | Rp3.84 Billion | — |